CaryHealth Clair vs Rejoy Health (2026)
Two small clinical AI platforms at the thin end of this category, and the comparison is mostly about which one publishes enough to evaluate. Clair is a reference product with a bounded corpus of public drug, trial and guideline sources, responses linked back to their references, named retrieval technique and a published interface for embedding. Rejoy claims a much wider product line for a company of its size, from chat assistance through several adjacent tools, and publishes a pricing page, which is more than most here. But it describes no oversight mechanism of any kind on a surface that touches real patient data, and its single technical claim is a benchmark result that does not hold up on inspection. Between two thinly documented vendors, take the one whose claims are narrower and checkable.
- The corpus is bounded and named, running over public drug, trial and guideline sources, with every response linked back to its original references and source routing described.
- It names more technique than several better graded peers, describing retrieval and grounding rather than gesturing at advanced reasoning.
- A published interface documentation site means another product can embed the reference layer rather than adopting the application.
- The product line is unusually wide for a company of this size, spanning chat assistance and adjacent clinical tools rather than reference alone.
- A dedicated pricing page exists and is linked from the main navigation, which is more commercial openness than most of this segment offers.
- For a small clinic wanting several capabilities from one vendor, breadth reduces the number of relationships to manage.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. CaryHealth Clair and Rejoy Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | CaryHealth Clair | Rejoy Health |
|---|---|---|
| Primary category | Clinical Reference & Evidence | Clinical Reference & Evidence |
| Headquarters | Washington, District of Columbia | San Francisco, California |
| Website | cary.health | rejoyhealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards CaryHealth Clair its top capability grade on AI Centrality. Set against Rejoy Health, CaryHealth Clair grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Its thinnest published disclosure sits on Clinical and Operational Evidence, AI Governance and Bias Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Rejoy Health its top capability grade on AI Centrality. Set against CaryHealth Clair, Rejoy Health does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose CaryHealth Clair or Rejoy Health?
The AI Health Index grades CaryHealth Clair higher than Rejoy Health on every axis that separates them, several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Rejoy Health does not grade higher on any scored axis.
Where do CaryHealth Clair and Rejoy Health differ most?
The widest separation the AI Health Index records between CaryHealth Clair and Rejoy Health is on Autonomy and Oversight Model, where CaryHealth Clair grades C and Rejoy Health grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do CaryHealth Clair and Rejoy Health grade the same?
The AI Health Index grades CaryHealth Clair and Rejoy Health the same on several axes, including AI Centrality, Clinical and Operational Evidence and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have CaryHealth Clair and Rejoy Health not disclosed?
At the last review, at least one of CaryHealth Clair and Rejoy Health published thin or absent detail on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records are thin in the same places and one is thinner. Neither publishes a security certification of any kind, an accuracy measurement, an error rate or a governance artefact. Rejoy describes no oversight mechanism at all across two retrieval passes on a surface that touches substantial patient data, and its only technical disclosure is a benchmark claim that does not survive examination, which is a different failure from silence. For any reference product the standing question is what happens when the source is superseded, and neither publishes a review cycle or a mechanism for detecting a stale entry.